Dattola, A. (2025) “Evaluating the Efficacy of Bimekizumab Across Different Sensitive Areas in Moderate-to-Severe Psoriasis: 52-week Multicentric Real-Life Experience in Lazio, Italy”, Dermatology Practical & Conceptual, 15(2), p. 4976 . doi:10.5826/dpc.1502a4976.